RUNX1 and acute myeloid leukemia: Previously, EVI1 and atRA were found to cooperate to enhance anti-leukemic activities in AML samples and cell lines29,30, while our study, focusing on LSCs, indicated the opposite, resulting in diverging assumptions about the possible utility of retinoids in the therapy of EVI1high AML.